Compare RAYA & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAYA | PPCB |
|---|---|---|
| Founded | 2019 | 2007 |
| Country | China | Australia |
| Employees | N/A | 2 |
| Industry | Metal Fabrications | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 2.3M |
| IPO Year | 2021 | N/A |
| Metric | RAYA | PPCB |
|---|---|---|
| Price | $4.11 | $0.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 15.1M | 5.8M |
| Earning Date | 04-17-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.95 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $0.09 |
| 52 Week High | $10.14 | $10.69 |
| Indicator | RAYA | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 67.36 | 34.44 |
| Support Level | $3.35 | N/A |
| Resistance Level | $4.17 | $0.13 |
| Average True Range (ATR) | 0.48 | 0.01 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 51.61 | 8.10 |
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.